Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
US FDA approves revised SPA for Argos Therapeutics' phase III study of AGS ... - pharmabiz.com |
![]() |
![]() |
pharmabiz.com Biopharmaceutical company Argos Therapeutics Inc. has received the US Food & Drug Administration (FDA) approval of revised Special Protocol Assessment (SPA) for its phase III clinical study of AGS-003 for the treatment of metastatic renal cell |